Whitby will market Searle’s Theo-24
Executive Summary
Whitby acquires marketing rights to the theophylline anhydrous product from Searle for an undisclosed amount on Dec. 24. Searle will manufacture the product and also provide support services such as labeling and shipping during an unspecified transition period. Whitby cited "industry reports" placing annual sales of Theo-24 at "about $8 mil.".